Clinical fate of reversible non-ischemic left ventricular systolic dysfunction and its influencing factors

Jeong Geun Moon, Se Joong Rim, Jaemin Shim, Chul Min Ahn, Shin Ae Kang, Sungha Park, Eui Young Choi, Young Guk Ko, Seok Min Kang, Jong Won Ha, Yangsoo Jang, Namsik Chung, Seung Yun Cho

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background and Objectives: About 25% of the patients with non-ischemic left ventricular (LV) systolic dysfunction will improve spontaneously. However, little has been known about the fate of the patients stricken with heart failure after recovery from DV dysfunction. We hypothesized that the patients who recovered from non-ischemic LV dysfunction have a substantial risk for recurrent heart failure. Subjects and Methods: Fifty patients (32 males, mean age: 54.9 ± 12.4 years) who recovered from systolic heart failure (LV ejection fraction: an EF of 28.8 ± 7.2% at the initial presentation) to near-normal (LVEF >40% and a 10% or more increase in the absolute value) were monitored for the recurrence of heart failure. Patients with significant coronary artery disease were excluded. The etiologies of heart failure were idiopathic dilated cardiomyopathy (n=39), alcoholic cardiomyopathy (n=7), adriamycin-induced cardiomyopathy (n=2), and tachycardia-induced cardiomyopathy (n=2). After recovery of LV dysfunction, the patients were followed up for a mean of 41.0 ± 26.3 months. Results: In 9 patients (18%), the LV systolic dysfunction recurred during follow-up (LVEF 32.6 ± 7.3%). There was no significant difference in the baseline clinical and echocardiographic variables between the patients with and without recurrent heart failure. However, cessation of anti-heart failure medication was more frequently observed in the patients with recurrent LV systolic dysfunction (55.6% vs 4.9%, respectively, p<0.05). Conclusion: Recurrent heart failure may ensue in the patients with reversible non-ischemic LV systolic dysfunction. The maintenance of anti-heart failure medication in these patients may be a significant influencing factor for their clinical prognosis.

Original languageEnglish
Pages (from-to)53-59
Number of pages7
JournalKorean Circulation Journal
Volume36
Issue number1
Publication statusPublished - 2006 Jan 1
Externally publishedYes

Fingerprint

Left Ventricular Dysfunction
Heart Failure
Cardiomyopathies
Alcoholic Cardiomyopathy
Systolic Heart Failure
Dilated Cardiomyopathy
Tachycardia
Stroke Volume
Doxorubicin
Coronary Artery Disease
Maintenance
Recurrence

Keywords

  • Congestive heart failure
  • Prognosis

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Moon, J. G., Rim, S. J., Shim, J., Ahn, C. M., Kang, S. A., Park, S., ... Cho, S. Y. (2006). Clinical fate of reversible non-ischemic left ventricular systolic dysfunction and its influencing factors. Korean Circulation Journal, 36(1), 53-59.

Clinical fate of reversible non-ischemic left ventricular systolic dysfunction and its influencing factors. / Moon, Jeong Geun; Rim, Se Joong; Shim, Jaemin; Ahn, Chul Min; Kang, Shin Ae; Park, Sungha; Choi, Eui Young; Ko, Young Guk; Kang, Seok Min; Ha, Jong Won; Jang, Yangsoo; Chung, Namsik; Cho, Seung Yun.

In: Korean Circulation Journal, Vol. 36, No. 1, 01.01.2006, p. 53-59.

Research output: Contribution to journalArticle

Moon, JG, Rim, SJ, Shim, J, Ahn, CM, Kang, SA, Park, S, Choi, EY, Ko, YG, Kang, SM, Ha, JW, Jang, Y, Chung, N & Cho, SY 2006, 'Clinical fate of reversible non-ischemic left ventricular systolic dysfunction and its influencing factors', Korean Circulation Journal, vol. 36, no. 1, pp. 53-59.
Moon, Jeong Geun ; Rim, Se Joong ; Shim, Jaemin ; Ahn, Chul Min ; Kang, Shin Ae ; Park, Sungha ; Choi, Eui Young ; Ko, Young Guk ; Kang, Seok Min ; Ha, Jong Won ; Jang, Yangsoo ; Chung, Namsik ; Cho, Seung Yun. / Clinical fate of reversible non-ischemic left ventricular systolic dysfunction and its influencing factors. In: Korean Circulation Journal. 2006 ; Vol. 36, No. 1. pp. 53-59.
@article{f030dee2882644de851ae3a60085636d,
title = "Clinical fate of reversible non-ischemic left ventricular systolic dysfunction and its influencing factors",
abstract = "Background and Objectives: About 25{\%} of the patients with non-ischemic left ventricular (LV) systolic dysfunction will improve spontaneously. However, little has been known about the fate of the patients stricken with heart failure after recovery from DV dysfunction. We hypothesized that the patients who recovered from non-ischemic LV dysfunction have a substantial risk for recurrent heart failure. Subjects and Methods: Fifty patients (32 males, mean age: 54.9 ± 12.4 years) who recovered from systolic heart failure (LV ejection fraction: an EF of 28.8 ± 7.2{\%} at the initial presentation) to near-normal (LVEF >40{\%} and a 10{\%} or more increase in the absolute value) were monitored for the recurrence of heart failure. Patients with significant coronary artery disease were excluded. The etiologies of heart failure were idiopathic dilated cardiomyopathy (n=39), alcoholic cardiomyopathy (n=7), adriamycin-induced cardiomyopathy (n=2), and tachycardia-induced cardiomyopathy (n=2). After recovery of LV dysfunction, the patients were followed up for a mean of 41.0 ± 26.3 months. Results: In 9 patients (18{\%}), the LV systolic dysfunction recurred during follow-up (LVEF 32.6 ± 7.3{\%}). There was no significant difference in the baseline clinical and echocardiographic variables between the patients with and without recurrent heart failure. However, cessation of anti-heart failure medication was more frequently observed in the patients with recurrent LV systolic dysfunction (55.6{\%} vs 4.9{\%}, respectively, p<0.05). Conclusion: Recurrent heart failure may ensue in the patients with reversible non-ischemic LV systolic dysfunction. The maintenance of anti-heart failure medication in these patients may be a significant influencing factor for their clinical prognosis.",
keywords = "Congestive heart failure, Prognosis",
author = "Moon, {Jeong Geun} and Rim, {Se Joong} and Jaemin Shim and Ahn, {Chul Min} and Kang, {Shin Ae} and Sungha Park and Choi, {Eui Young} and Ko, {Young Guk} and Kang, {Seok Min} and Ha, {Jong Won} and Yangsoo Jang and Namsik Chung and Cho, {Seung Yun}",
year = "2006",
month = "1",
day = "1",
language = "English",
volume = "36",
pages = "53--59",
journal = "Korean Circulation Journal",
issn = "1738-5520",
publisher = "Korean Society of Circulation",
number = "1",

}

TY - JOUR

T1 - Clinical fate of reversible non-ischemic left ventricular systolic dysfunction and its influencing factors

AU - Moon, Jeong Geun

AU - Rim, Se Joong

AU - Shim, Jaemin

AU - Ahn, Chul Min

AU - Kang, Shin Ae

AU - Park, Sungha

AU - Choi, Eui Young

AU - Ko, Young Guk

AU - Kang, Seok Min

AU - Ha, Jong Won

AU - Jang, Yangsoo

AU - Chung, Namsik

AU - Cho, Seung Yun

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Background and Objectives: About 25% of the patients with non-ischemic left ventricular (LV) systolic dysfunction will improve spontaneously. However, little has been known about the fate of the patients stricken with heart failure after recovery from DV dysfunction. We hypothesized that the patients who recovered from non-ischemic LV dysfunction have a substantial risk for recurrent heart failure. Subjects and Methods: Fifty patients (32 males, mean age: 54.9 ± 12.4 years) who recovered from systolic heart failure (LV ejection fraction: an EF of 28.8 ± 7.2% at the initial presentation) to near-normal (LVEF >40% and a 10% or more increase in the absolute value) were monitored for the recurrence of heart failure. Patients with significant coronary artery disease were excluded. The etiologies of heart failure were idiopathic dilated cardiomyopathy (n=39), alcoholic cardiomyopathy (n=7), adriamycin-induced cardiomyopathy (n=2), and tachycardia-induced cardiomyopathy (n=2). After recovery of LV dysfunction, the patients were followed up for a mean of 41.0 ± 26.3 months. Results: In 9 patients (18%), the LV systolic dysfunction recurred during follow-up (LVEF 32.6 ± 7.3%). There was no significant difference in the baseline clinical and echocardiographic variables between the patients with and without recurrent heart failure. However, cessation of anti-heart failure medication was more frequently observed in the patients with recurrent LV systolic dysfunction (55.6% vs 4.9%, respectively, p<0.05). Conclusion: Recurrent heart failure may ensue in the patients with reversible non-ischemic LV systolic dysfunction. The maintenance of anti-heart failure medication in these patients may be a significant influencing factor for their clinical prognosis.

AB - Background and Objectives: About 25% of the patients with non-ischemic left ventricular (LV) systolic dysfunction will improve spontaneously. However, little has been known about the fate of the patients stricken with heart failure after recovery from DV dysfunction. We hypothesized that the patients who recovered from non-ischemic LV dysfunction have a substantial risk for recurrent heart failure. Subjects and Methods: Fifty patients (32 males, mean age: 54.9 ± 12.4 years) who recovered from systolic heart failure (LV ejection fraction: an EF of 28.8 ± 7.2% at the initial presentation) to near-normal (LVEF >40% and a 10% or more increase in the absolute value) were monitored for the recurrence of heart failure. Patients with significant coronary artery disease were excluded. The etiologies of heart failure were idiopathic dilated cardiomyopathy (n=39), alcoholic cardiomyopathy (n=7), adriamycin-induced cardiomyopathy (n=2), and tachycardia-induced cardiomyopathy (n=2). After recovery of LV dysfunction, the patients were followed up for a mean of 41.0 ± 26.3 months. Results: In 9 patients (18%), the LV systolic dysfunction recurred during follow-up (LVEF 32.6 ± 7.3%). There was no significant difference in the baseline clinical and echocardiographic variables between the patients with and without recurrent heart failure. However, cessation of anti-heart failure medication was more frequently observed in the patients with recurrent LV systolic dysfunction (55.6% vs 4.9%, respectively, p<0.05). Conclusion: Recurrent heart failure may ensue in the patients with reversible non-ischemic LV systolic dysfunction. The maintenance of anti-heart failure medication in these patients may be a significant influencing factor for their clinical prognosis.

KW - Congestive heart failure

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=33644586319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644586319&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 53

EP - 59

JO - Korean Circulation Journal

JF - Korean Circulation Journal

SN - 1738-5520

IS - 1

ER -